Trial Profile
A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-330 and D086 Combination Therapy in Hypertensive Patients With Dyslipidemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2019
Price :
$35
*
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary) ; D 086 (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Chong Kun Dang
- 22 Jul 2019 Status changed from recruiting to completed.
- 19 Jul 2018 New trial record